Clinicians and researchers can use the new “Quality of Life in People with Hearing Loss Questionnaire (HL-QoL)” to assess how hearing loss and treatment affect an individual’s quality of life. As the first validated questionnaire based on the WHO’s international classification of functioning, disability, and health, it is designed to assess hearing outcomes while providing a holistic perspective.

The early activation of cochlear implant audio processors is an option that growing numbers of hearing implant clinics now offer. This article summarizes recent publications on early activation in cochlear implantation and its reported impact on patient care, safety, impedance values, fitting parameters, audiological outcomes, complications, and more.

Stimulating the right pitch at the right rate and at the right place in the cochlea enables people with hearing loss to hear with their cochlear implants in a way that comes uniquely close to natural hearing. Simple, right? Not at all. MED-EL’s sophisticated technology that enables closest to natural hearing is anything but simple. Read on to find out what sets us apart from other CI manufacturers and why we are the worldwide leader when it comes to cochlear implant sound quality.

MED-EL has long been a leader in cochlear implant innovation, committed to delivering hearing solutions that closely replicate natural hearing. In partnership with Starkey, a global leader in hearing aid technology, MED-EL introduces DualSync—a breakthrough in bimodal streaming that enables seamless audio delivery to both ears via Apple devices.

Research related to balance disorders is now rapidly advancing. For many professionals focused primarily on hearing care, it may seem increasingly difficult to stay up to date on vestibular topics. That’s why, as part of Vestibular Awareness Week 2025, we are proud to help get the word out to clinicians and ENT practices around the world.

Professor Mario Zernotti, our guest author, shares insights gained from nearly four decades of experience helping children with conductive hearing loss due to microtia and congenital aural atresia, which occurs most commonly in Andes Mountains of South America.